IGC Pharma, Inc.
IGC Pharma, Inc. (IGC): 7 pipeline candidates · ~1 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.2 months
D/E 0.50 · 0% dilution
Lead: Phase 2
7 candidates
N/A
N/A
A transparent, data-derived signal for IGC Pharma, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$28.5M
Cash
$207K
Quarterly Burn
$1.2M
Runway
1.2 mo
Revenue
$317K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
35
Total value held
$1.3M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,436,872 | $378K |
| geode capital management, llc | 1,043,384 | $274K |
| blackrock, inc. | 703,798 | $185K |
| renaissance technologies llc | 483,975 | $127K |
| vanguard fiduciary trust co | 415,888 | $109K |
| state street corp | 200,799 | $53K |
| susquehanna international group, llp | 122,595 | $32K |
| northern trust corp | 113,407 | $30K |
| lawood & co | 75,000 | $20K |
| goldman sachs group inc | 65,541 | $17K |
Showing top 10 of 35 institutional holders of IGC Pharma, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in IGC Pharma, Inc.'s pipeline?
IGC Pharma, Inc. (IGC) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is IGC Pharma, Inc.'s lead drug candidate?
IGC Pharma, Inc.'s most advanced tracked candidate is igc-1a (Preclinical) for Metabolic disorders (e.g., type 2 diabetes, obesity).
What is IGC Pharma, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, IGC Pharma, Inc. has approximately 1.2 months of cash runway.
What is IGC Pharma, Inc.'s market capitalization?
IGC Pharma, Inc.'s market capitalization is approximately $28.5M.
Who is the CEO of IGC Pharma, Inc.?
Mr. Ram Mukunda is the chief executive officer of IGC Pharma, Inc. (IGC).
Get the full picture on IGC Pharma, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.